• Ability to tailor diagnostics, therapeutics to specific patients is key to precision medicine
• Global precision oncology market projected to grow at CAGR of 9.9% over the next eight years, will reach $99.7 billion by 2027
• Varian Bio making significant headway in development of two preclinical experimental cancer drugs

Healthtech Solutions (OTC: HLTT) is making a strong statement with its most recent acquisition. HLTT acquired Varian Biopharmaceuticals, a precision oncology company developing novel therapeutics for the treatment of cancer —and with the acquisition, the company is making its entry into the precision cancer care market (https://ibn.fm/IaAcf).

“Precision medicine is a concept that collectively integrates the outcomes and the endeavors of research and healthcare,” states a recent Research and Markets article (https://ibn.fm/PWUBE). “The ability to tailor the diagnostics and therapeutics offered to the patients is the key to…

Read More>>

NOTE TO INVESTORS: The latest news and updates relating to HLTT are available in the company’s newsroom at https://ibn.fm/HLTT

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.

With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.

Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.